RAC 0.00% $1.66 race oncology ltd

Speculative M&A Transaction Analysis, page-799

  1. 99 Posts.
    lightbulb Created with Sketch. 48
    yep, I saw that. I am sure when Gilead put down $4.9b they knew this end result was possible. I wonder what bisantrene's historical clinical data is worth to a potential buyer/license partner in terms of reducing a similar risk.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.66
Change
0.000(0.00%)
Mkt cap ! $282.8M
Open High Low Value Volume
$1.68 $1.68 $1.62 $102.7K 62.79K

Buyers (Bids)

No. Vol. Price($)
1 359 $1.65
 

Sellers (Offers)

Price($) Vol. No.
$1.66 249 1
View Market Depth
Last trade - 16.10pm 05/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.